DIA 2018 Global Annual Meeting

Component Type: Forum
Level: Basic
CE: ACPE 1.25 Knowledge UAN: 0286-0000-18-639-L04-P; CME 1.25; IACET 1.25; RN 1.25

Machine learning and artificial intelligence is a rapidly expanding field in many industries. The question is, are we ready for artificial intelligence in clinical trials? Are we ready to let machines and AI make decisions for our clinical trial space including: our research - which compounds to move forward, our portfolio- which protocols to run, our operations - which risk management actions to take? This session will include a quick introduction to the basic concepts of machine learning and artificial intelligence will be followed by highlighting emerging areas in clinical trials that can leverage machine learning and artificial intelligence, and how use of this intelligence can affect trial planning, oversight and execution.

Learning Objectives

Discuss how the world of machine learning and artificial intelligence is affecting clinical trials; Describe how artificial intelligence can affect regulatory and oversight processes in clinical trials.

Chair

Greg Jones

Speaker

Are You Ready for Artificial Intelligence in your Clinical Trial?
Greg Jones

Passive In-Home Patient Monitoring: The Role of AI and Contactless Sensors
Dina Katabi, PhD

The High ROI of Using Artificial Intelligence for Clinical Trials Recruitment
Wout Brusselaers, MA